Jinxiang Shugan Tablets

1. Evaluate the safety of Jinxiang Shugan Tablets in the treatment of mild and moderate depression (liver depression and spleen deficiency syndrome) in a wider population. 2. Evaluate the effectiveness of Jinxiang Shugan Tablets in the treatment of mild and moderate depression (liver depression and spleen deficiency syndrome), and observe the improvement of the main symptoms of sleep disorders and functional dyspepsia during the treatment process. 3. Analyze the heterogeneity of the clinical effect of Jinxiang Shugan Tablets, including population heterogeneity and treatment heterogeneity, to provide scientific guidance for the reasonable clinical application of Jinxiang Shugan Tablets.